1,3-dipropyl-8-cyclopentylxanthine has been researched along with Diabetic Nephropathies in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patinha, D | 1 |
| Fasching, A | 1 |
| Pinho, D | 1 |
| Albino-Teixeira, A | 1 |
| Morato, M | 1 |
| Palm, F | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Diabetic Nephropathies
| Article | Year |
|---|---|
Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.
Topics: Adenosine A1 Receptor Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; | 2013 |